ERG-1 Peptides and Polynucleotides and their Use in the Treatment and Diagnosis of Disease
The present invention relates to peptide and polynucleotide fragments of ERG-1, and in particular, human ERG-1a (HERG-1a) and its isoforms, and their use in the treatment and diagnosis of disease, especially cardiac diseases, such as arrhythmias, and cancer.
TRUDEAU MATTHEW C [US]
Type of Offer:
« More Biotech Patents